Insider Selling: Apellis Pharmaceuticals, Inc (NASDAQ:APLS) CFO Sells 4,000 Shares of Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
WALTHAM, Mass., April 01, 2024 Apellis Pharmaceuticals, Inc. today announced that the company will host a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Monday,.
Apellis Pharmaceuticals (APLS) Neutral Rating Reaffirmed at Mizuho theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Apellis Pharmaceuticals (NASDAQ:APLS) Stock Rating Reaffirmed by Mizuho themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Investment Analysts’ updated eps estimates for Wednesday, March 27th: Adobe (NASDAQ:ADBE) had its buy rating reaffirmed by analysts at Mizuho. The firm currently has a $680.00 price target on the stock. Apellis Pharmaceuticals (NASDAQ:APLS) had its neutral rating reiterated by analysts at Mizuho. Mizuho currently has a $60.00 target price on the stock. Alibaba Group […]